VicPlas International Ltd. (SG:569)
SGX:569
Want to see SG:569 full AI Analyst Report?
569 Stock Chart & Stats
S$0.09
<S$0.01(2.13%)
At close: 4:00 PM EST
S$0.09
<S$0.01(2.13%)
Day’s Range― - ―
52-Week RangeS$0.08 - S$0.10
Previous CloseN/A
Volume100.00
Average Volume (3M)97.25K
Market Cap
S$40.89M
Enterprise ValueS$78.80M
Total Cash (Recent Filing)S$4.71M
Total Debt (Recent Filing)S$41.11M
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Sep 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding511,537,700
10 Day Avg. Volume66,350
30 Day Avg. Volume97,253
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.65
Price to Sales (P/S)0.39
P/FCF Ratio-7.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Business SegmentsVicPlas sells both piping systems and medical devices, giving structurally different demand drivers. Diversification reduces dependence on a single end market and supports steadier revenues across construction cycles and secular healthcare growth over the next several months.
Top-line RecoveryA significant 2025 revenue rebound demonstrates the company’s ability to restore volume or pricing after a downturn. Sustained top-line recovery can provide the runway to absorb fixed costs, improve operating leverage, and restore profitability if management maintains cost discipline.
High Gross Margins And Equity BufferConsistently healthy gross margins indicate product-level pricing power or efficient production, supporting margin sustainability. Material equity balances provide a capital cushion to absorb shocks, fund working capital and investments while management addresses profitability and cash conversion.
Bears Say
Shift To Net LossesTransition from multi-year profits to recent losses signals persistent profitability pressure from higher operating costs, mix shifts, or one-offs. Continued negative earnings erode retained capital and limit reinvestment, making recovery dependent on sustained margin or cost improvements.
Weak Cash Generation And Negative FCFMaterial weakening of operating cash flow and recurring negative free cash flow reduce financial flexibility. With limited internal cash, the firm faces greater reliance on external funding for capex, working capital and debt service, constraining the ability to execute strategic initiatives.
Rising LeverageAn upward trend in leverage increases interest and refinancing risk, especially alongside weak cash flow and losses. Higher debt levels can constrain capital allocation, heighten covenant exposure and limit the company's ability to invest or respond to market setbacks over the medium term.
VicPlas International Ltd. News
569 FAQ
What was VicPlas International Ltd.’s price range in the past 12 months?
VicPlas International Ltd. lowest share price was S$0.07 and its highest was S$0.10 in the past 12 months.
What is VicPlas International Ltd.’s market cap?
VicPlas International Ltd.’s market cap is S$40.89M.
When is VicPlas International Ltd.’s upcoming earnings report date?
VicPlas International Ltd.’s upcoming earnings report date is Sep 25, 2026 which is in 103 days.
How were VicPlas International Ltd.’s earnings last quarter?
VicPlas International Ltd. released its earnings results on Mar 13, 2026. The company reported -S$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.007.
Is VicPlas International Ltd. overvalued?
According to Wall Street analysts VicPlas International Ltd.’s price is currently Overvalued.
Does VicPlas International Ltd. pay dividends?
VicPlas International Ltd. pays a N/A dividend of S$0.004 which represents an annual dividend yield of N/A. See more information on VicPlas International Ltd. dividends here
What is VicPlas International Ltd.’s EPS estimate?
VicPlas International Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VicPlas International Ltd. have?
VicPlas International Ltd. has 511,537,700 shares outstanding.
What happened to VicPlas International Ltd.’s price movement after its last earnings report?
VicPlas International Ltd. reported an EPS of -S$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.124%.
Which hedge fund is a major shareholder of VicPlas International Ltd.?
Currently, no hedge funds are holding shares in SG:569
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VicPlas International Ltd.
Vicplas International Ltd, established in Singapore in 1993, operates as an investment holding company with key business segments in medical devices and piping systems. The company's geographical reach includes Singapore, Malaysia, the People's Republic of China, and the United Kingdom. Its piping division focuses on the manufacturing, trading, and distribution of a variety of piping solutions. These systems are utilized for diverse applications such as waste and potable water management in residential, educational, commercial, and industrial settings; conduits for underground electrical and internal building wiring; and data and signal lines for telecommunication providers. Additionally, Vicplas is engaged in the design, development, production, and assembly of both sterile and non-sterile medical devices. The company also offers specialized project design and engineering services. Vicplas International Ltd is a subsidiary of Venner Capital S.A.
Technical Analysis
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
AJJ Medtech Holdings Limited
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―